Figure 3

Pre-treatment MRI (FLAIR and corresponding rCBV images) of six representative patients with IDH-1/2 mutant (a–c) and wild-type (d–f) gliomas. Histogram analysis demonstrates the distribution of rCBV-voxels, with IDH-1/2 mutant tumors clustering at substantially lower values as compared to their wild-type counterpart.